No Picture
News

Rigel Announces Investigator-Sponsored Trial of Fostamatinib in Patients with COVID-19 Pneumonia

High content screen identifies fostamatinib as a candidate for repurposing for Acute Lung Injury

SOUTH SAN FRANCISCO, Calif., July 14, 2020 /PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the initiation of an investigator-s… […]

No Picture
News

IDEAYA to Participate in Fireside Chat at BTIG Biotechnology Conference and Wedbush PacGrow Healthcare Conference on August 11 and 12, 2020

SOUTH SAN FRANCISCO, Calif., July 14, 2020 /PRNewswire/ — IDEAYA Biosciences, Inc. (Nasdaq: IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics, announced the Company will parti… […]

No Picture
News

Kodiak Sciences Announces New Longer-Term Safety, Efficacy and Durability Data from Ongoing Phase 1b Study of KSI-301 in Patients with Wet Age-Related Macular Degeneration, Diabetic Macular Edema and Retinal Vein Occlusion at the American Society of Retina Specialists (ASRS) 2020 Virtual Annual Meeting

– Strong anti-VEGF safety, efficacy and durability continue to be observed across all three of the major retinal vascular diseases, with most patients achieving treatment-free intervals of 6-months in wet AMD, 6-months or longer in DME, and 4-months o… […]

No Picture
News

Anixa Biosciences’ CAR-T Cancer Therapy Receives Intention to Grant Notice from the European Patent Office

SAN JOSE, Calif., July 10, 2020 /PRNewswire/ — Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced that the European Patent Office has issued an … […]

No Picture
News

NuMedii Announces Creation of World’s First Single-Cell Sequencing Atlas for Idiopathic Pulmonary Fibrosis by its Collaborators

SAN MATEO, Calif., July 9, 2020 /PRNewswire/ — NuMedii, Inc., a data-driven drug discovery company, today announced the availability of the world’s first single-cell sequencing atlas for idiopathic pulmonary fibrosis (IPF) that was the result of a … […]

No Picture
News

IDEAYA Biosciences Doses First Patient in a Phase 1 Combination Study of IDE196 and Binimetinib, a MEK Inhibitor

SOUTH SAN FRANCISCO, Calif., July 9, 2020 /PRNewswire/ — IDEAYA Biosciences, Inc. (NASDAQ:IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics, announced First-Patient-In (FPI) in… […]

No Picture
News

ValGenesis VLMS to Digitize Validation Lifecycle Processes for Fast Growing Biopharmaceutical Company

SAN FRANCISCO, July 8, 2020 /PRNewswire/ — ValGenesis, Inc., a market leader in Enterprise Validation Lifecycle Management solutions, today announced that a fast growing research based biopharmaceutical company has chosen the ValGenesis Validation … […]